Lv71
4988 积分 2021-08-05 加入
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
17天前
已完结
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
17天前
已完结
CAR T-cell therapies in China: rapid evolution and a bright future
17天前
已完结
Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development
17天前
已完结
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
24天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
2个月前
已完结
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
2个月前
已完结
Anti CD19 targeting CAR T cell therapy in ANCA-associated vasculitis
2个月前
已完结
皖公网安备34019202002308
